segment

Medical devices and diagnostics

Transform your business through intelligent workflows and valuable insights

Virtusa is your full service innovation partner

Schedule a vLife® demo

Virtusa helps medical device organizations capitalize on the virtualization and personalization movement by leveraging digital technologies such as automation, advanced analytics and insights, AI/ML, cognitive, and IoT. There is no better initiative to move the industry forward in chronic disease care.

Virtusa is a full-stack digital engineering services partner driving innovation at speed. Our solutions are engineered for adoption, by your customers & patients. We partner effectively with business, R&D, and IT teams, manage the platforms we build, and excel in outcomes-based models.

Our digital engineering solutions support the management of the top five chronic diseases in America

Renal care

37 million American adults are estimated to suffer from Chronic Kidney Disease (CKD). In 2017, Medicare costs for all people with all stages of CKD were $120 billion.

Virtusa has partnered with industry leaders to develop connectivity and insights for home dialysis care, AI/ML algorithms for identifying T2D patients at risk for chronic kidney disease, and EMR interoperability appliance for in-center dialysis.

Orthopedics

126.6 million Americans are affected by a musculoskeletal condition costing $213 billion for annual treatment.

Virtusa has pioneered launch of digital surgery platform through ML-based risk stratification leveraging EMR interoperability, personalized care plans, mobile app for patient engagement through Continuum of Care (CoC) and surgeon portal to promote tighter care coordination post-surgery.

Diabetes

34.2 million Americans have diabetes. In 2017, the total estimated cost of diagnosed diabetes in the U.S. was $327 billion.

Virtusa’s unique interoperable/payment evidence-based remote patient monitoring solution has kickstarted transformation of revenue for diabetic device companies from product-based to service-based.

Cardiovascular

Chronic heart disease costs up to $219 billion in 2015.

Field assets especially those with the patient are critical for their ongoing care. Knowing their status and being able to proactively manage them improves patient outcomes and provide experience.

Virtusa’s field asset management solution combines a dynamic Operational Data Store (ODS) with automated workflows in ServiceNow for insights generation, automated outreach and faster service for in-bound calls leading to operational efficiencies, asset waste reduction and increases cross-selling opportunities.

Respiratory

37 million Americans live with a chronic lung disease such as asthma and Chronic Obstructive Pulmonary Disease (COPD). Costs attributed to Chronic Lung Disease are projected to be $127 billion in 2020.

Virtusa’s unique IoT driven remote patient monitoring and AI/ML enabled predictive analytics is interoperable with EMRs and payor care management services to enable care transformation for patients with chronic respiratory diseases.

Our perspectives

Virtusa’s technology and industry experts share knowledge on tackling current business and digital transformation challenges. Get key tips and insights to inspire new thinking, avoid pitfalls, and drive higher results.

Where medical device industry leaders turn for digital transformation

Enabling customers to drive competitive advantage through digital transformation in medical devices and diagnostics

Capabilities

Virtusa leads the industry in its ability to drive transformation through innovation and AI, all things data, personalized, contextual, automated, and interactive engagement through lowcode-nocode platforms, and enterprise-grade solutions around CRM, ERP, managed services, and cloud. We have built solutions tailored to support programs for chronic diseases such as diabetes, cardiovascular, chronic kidney disease, respiratory and musculoskeletal disorders.

vLife® Healthcare and Life Sciences Applications Marketplace

The life science industry has been a late adopter of most innovative technologies, despite the large R&D budgets. vLife‚ serves as a medium to bridge the gap among various stakeholders of the industry and accelerate innovation.

Digital Engineering Services

Virtusa combines engineering best practices and industry expertise to help clients drive digital transformation at scale, improve performance and stay ahead of the competition.

Experience-led engineering

With experience-led engineering and our Design KickStart approach, we're designing solutions that are Engineered for Adoption.

Analytics, Insights and Data Services

We help organizations with their Digital transformation initiatives by modernizing their data platforms and applying AI/ML to redefine, re-engineer their business processes leading to superior customer experience and higher productivity.

Digital Process Automation

Virtusa's Digital Process Automation practice collaborates with large and medium-scale enterprises and utilizes its dedicated experts to drive core automation benefits such as cost efficiencies, faster time-to-market, and improved customer service.

Lift and shift migration

Virtusa delivers an end-to-end migration approach that accelerates concept to reality by delivering future-ready platforms.

Partnerships and recognitions

Everest Group Recognizes Virtusa as a Major Contender

in its Medical Devices Digital Services PEAK Matrix® Assessment 2020

2019 & 2020 Pegasystems Partner Award

Excellence in Digital Transformation

2020 SIIA CODiE Award

Best Healthcare Technology Solution

Three Gold Stevie® Awards in 2019 International Business Awards

Virtusa Recognized for Leadership

HITRUST CSF Certified

Virtusa is HITRUST CSF Certified for information security on the following platforms: active directory, endpoints, and network devices. The HITRUST CSF Certified status demonstrates that the organization’s application development, testing, production support, and infrastructure management services teams have met key regulations and industry-defined requirements and are appropriately managing risk.

Meet our leaders

Anthony Lange

Senior Vice President & Head of Healthcare and Life Sciences,
Americas

Manu Swami

Senior Vice President & Head of Solutions,
Healthcare and Life Sciences,
Americas

Santanu Sen

Vice President and Head of Life Sciences,
Americas

Chinmay Pradhan

Vice President,
Client Services,
Healthcare and Life Sciences,
Americas

Ram Rajagopalan

Senior Director,
Healthcare and Life Sciences,
Americas

Find out what Virtusa can do for you

Request a healthcare and life sciences consultation

First Name
Last Name
Job Title
Organization
Email
Phone
Comment or Question
Contact Us

First Name

Last Name

Job Title

Organization

Phone

Comment or Question

Yes, I want Virtusa to keep me up-to-date with recent industry developments including insights, upcoming events, and innovative solution capabilities according to the privacy policy

Medical devices and diagnostics

Renal care

37 million American adults are estimated to suffer from Chronic Kidney Disease (CKD). In 2017, Medicare costs for all people with all stages of CKD were $120 billion.

Orthopedics

126.6 million Americans are affected by a musculoskeletal condition costing $213 billion for annual treatment.

Diabetes

34.2 million Americans have diabetes. In 2017, the total estimated cost of diagnosed diabetes in the U.S. was $327 billion.

Cardiovascular

Chronic heart disease costs up to $219 billion in 2015.

Respiratory

37 million Americans live with a chronic lung disease such as asthma and Chronic Obstructive Pulmonary Disease (COPD). Costs attributed to Chronic Lung Disease are projected to be $127 billion in 2020.

Our perspectives

Where medical device industry leaders turn for digital transformation

Capabilities

vLife® Healthcare and Life Sciences Applications Marketplace

Digital Engineering Services

Experience-led engineering

Analytics, Insights and Data Services

Digital Process Automation

Lift and shift migration

Partnerships and recognitions

Everest Group Recognizes Virtusa as a Major Contender

2019 & 2020 Pegasystems Partner Award

2020 SIIA CODiE Award

Three Gold Stevie® Awards in 2019 International Business Awards

HITRUST CSF Certified

Meet our leaders

Anthony Lange

Manu Swami

Santanu Sen

Chinmay Pradhan

Ram Rajagopalan

Take the Future Fitness Assessment:
Cloud Adoption

Virtusa named leader in Pega Services

Virtusa Cares

Success stories

Medical devices and diagnostics

Renal care

37 million American adults are estimated to suffer from Chronic Kidney Disease (CKD). In 2017, Medicare costs for all people with all stages of CKD were $120 billion.

Orthopedics

126.6 million Americans are affected by a musculoskeletal condition costing $213 billion for annual treatment.

Diabetes

34.2 million Americans have diabetes. In 2017, the total estimated cost of diagnosed diabetes in the U.S. was $327 billion.

Cardiovascular

Chronic heart disease costs up to $219 billion in 2015.

Respiratory

37 million Americans live with a chronic lung disease such as asthma and Chronic Obstructive Pulmonary Disease (COPD). Costs attributed to Chronic Lung Disease are projected to be $127 billion in 2020.

Our perspectives

Where medical device industry leaders turn for digital transformation

Capabilities

vLife® Healthcare and Life Sciences Applications Marketplace

Digital Engineering Services

Experience-led engineering

Analytics, Insights and Data Services

Digital Process Automation

Lift and shift migration

Partnerships and recognitions

Everest Group Recognizes Virtusa as a Major Contender

2019 & 2020 Pegasystems Partner Award

2020 SIIA CODiE Award

Three Gold Stevie® Awards in 2019 International Business Awards

HITRUST CSF Certified

Meet our leaders

Anthony Lange

Manu Swami

Santanu Sen

Chinmay Pradhan

Ram Rajagopalan

Take the Future Fitness Assessment: Cloud Adoption

Virtusa named leader in Pega Services

Virtusa Cares

Success stories

Take the Future Fitness Assessment:
Cloud Adoption